Agree that adding FTO inhibition is a way of protecting keytruda sales. I am wondering though whether it is eventually paired as default standard of care OR whether the addition of FTO inhibitor is only tests show that FTO is over expressed.
Pillar 1 - FTO (new thread), page-50
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
-0.015(0.96%) |
Mkt cap ! $257.8M | |||
| Open | High | Low | Value | Volume |
| $1.59 | $1.59 | $1.51 | $189.1K | 121.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200 | $1.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.55 | 999 | 1 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.52 |
Change
-0.015 ( 2.88 %) |
||||
| Open | High | Low | Volume | ||
| $1.55 | $1.58 | $1.51 | 7772 | ||
| Last updated 15.59pm 17/05/2024 ? | |||||
| RAC (ASX) Chart |